Malignant potential of intraductal papillary mucinous neoplasm (IPMN) of the pancreas: imaging assessment of IPMN-derived cancer and concomitant pancreatic ductal adenocarcinoma
Open Access
- 30 August 2026
- journal article
- review article
- Published by Springer Nature in Japanese Journal of Radiology
- p. 1-24
Abstract
The detection of pancreatic cystic lesions (PCLs) has increased markedly with the widespread use of cross-sectional imaging. Although the true proportion of intraductal papillary mucinous neoplasms (IPMNs) among PCLs remains uncertain, IPMN is considered to account for most PCLs and is a representative precursor lesion of pancreatic ductal adenocarcinoma (PDAC). However, not all PCLs should be assumed to represent IPMN, because this assumption may lead to unnecessary surveillance or overtreatment. Therefore, radiologists should first determine whether a PCL truly represents IPMN, particularly by differentiating it from lesions without malignant potential, such as serous cystic neoplasm. Once IPMN is diagnosed, appropriate risk stratification is required to identify IPMN-derived cancer, defined in this review as IPMN with high-grade dysplasia or associated invasive carcinoma. High-risk stigmata and worrisome features proposed in current guidelines are central to this assessment. However, the risk associated with each factor is not uniform; therefore, risk assessment and management decisions should consider both the number of risk factors present and the relative weight of each factor. Concomitant PDAC may also arise separately from the PCL, possibly reflecting a field defect of the entire pancreas. Unlike IPMN-derived cancer, concomitant PDAC may develop independently of cyst size or growth and is often detected at an advanced stage. Therefore, surveillance of patients with IPMN should include not only evaluation of the PCL itself and assessment for IPMN-derived cancer, but also systematic assessment of the entire pancreas for concomitant PDAC. This review discusses the differential diagnosis of PCLs, imaging assessment of IPMN-derived cancer, the concept and imaging clues of concomitant PDAC, and practical considerations for surveillance strategies.Keywords
This publication has 79 references indexed in Scilit:
- High Burden of Pancreatic Surgery for Intraductal Papillary Mucinous Neoplasia With Low‐Grade Dysplasia and Benign Cysts: A Systematic Review and Meta‐AnalysisUnited European Gastroenterology Journal, 2025
- Comparison of intra- and inter-reader agreement of abbreviated versus comprehensive MRCP for pancreatic cyst surveillanceAbdominal Radiology, 2024
- Long-Term Outcomes and Risk of Pancreatic Cancer in Intraductal Papillary Mucinous NeoplasmsJAMA Network Open, 2023
- Clinical Characteristics of Patients With Surgically Resected Pancreatic Cysts: A Retrospective Analysis of 136 PatientsJournal of Ultrasound in Medicine, 2022
- MRI follow-up for pancreatic intraductal papillary mucinous neoplasm: an ultrashort versus long protocolAbdominal Radiology, 2021
- Computed tomography nomogram to predict a high-risk intraductal papillary mucinous neoplasm of the pancreasAbdominal Radiology, 2021
- Importance of main pancreatic duct dilatation in IPMN undergoing surveillanceBritish Journal of Surgery, 2018
- Predictive performance of factors associated with malignancy in intraductal papillary mucinous neoplasia of the pancreasBJS Open, 2018
- Mucinous nonneoplastic cyst of the pancreas: CT and MRI appearancesAbdominal Radiology, 2017
- Incidental pancreatic cysts on 3D turbo spin echo magnetic resonance cholangiopancreatography: prevalence and relation with clinical and imaging featuresAbdominal Radiology, 2010